Solothurner Spitäler AG
Solothurn, Switzerland
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationReimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
- ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
- Websitehttps://www.solothurnerspitaeler.ch/unsere-spitaeler/psychiatrische-dienste
About this provider
The Psychiatrische Dienste of Solothurner Spitäler AG (soH) hold the mandate for comprehensive psychiatric care across the canton of Solothurn, with around 540 staff at several locations treating adults, adolescents and children on an outpatient, day-clinic or inpatient basis. Its Behandlungszentrum für Angst und Depression at Weissensteinstrasse 102 in Solothurn serves adults aged 18 and over with depression, burnout, anxiety and obsessive-compulsive disorders and sleep disorders, drawing on a range of medical and therapeutic treatment options.
Services & programs
- Treatment centre for anxiety and depression (Behandlungszentrum für Angst und Depression), adults 18+
- Outpatient, day-clinic and inpatient psychiatric care
- Old-age psychiatry
- Child and adolescent psychiatric services
- Cantonal psychiatric care mandate for Solothurn
Common questions
How do I start Spravato treatment via the Solothurn psychiatric services?
The Swiss route runs through a psychiatrist: eligibility under the Limitatio (adults 18-74, failure of at least two antidepressants plus one augmentation in the current episode, CGI-S of 5 or more) must be documented and the insurer's cost approval (Kostengutsprache) obtained before the first dose.
How long does reimbursed treatment last?
Basic insurance covers Spravato for a maximum of 10 months per the BAG Limitatio; continuation beyond that is not reimbursed under the standard listing.
Verification
- License / registryBAG SL Limitatio
- Sourcehttps://www.bag.admin.ch/dam/de/sd-web/uo93E02fcJBh/Liste%20der%20Zentren%20gem%C3%A4ss%20der%20Limitierung%20von%20Spravato_20251001.pdf
- Last verified